crotogoudin: has antineoplastic activity; structure in first source
ID Source | ID |
---|---|
PubMed CID | 72945874 |
MeSH ID | M000609035 |
Synonym |
---|
crotogoudin |
DTXSID001104158 |
2h-7a,10-ethanonaphtho[8a,1-b]pyran-2,8(9h)-dione, octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-, (4ar,5r,7as,10s,11ar)- |
(4ar,5r,7as,10s,11ar)-octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-2h-7a,10-ethanonaphtho[8a,1-b]pyran-2,8(9h)-dione |
unii-pf2yff2459 |
(4ar,5r,7as,10s,11ar)-octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-2h-7a,10-ethanonaphtho(8a,1-b)pyran-2,8(9h)-dione |
1252665-39-6 |
pf2yff2459 , |
2h-7a,10-ethanonaphtho(8a,1-b)pyran-2,8(9h)-dione, octahydro-4a-methyl-9-methylene-5-(1-methylethenyl)-, (4ar,5r,7as,10s,11ar)- |
ent-crotogoudin |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (20.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (80.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |